Back to marketplace
ROYALCAREHOSPITALSUNLISTED· ISIN INE02C801010· Coimbatore, Tamil Nadu, India· Est. 2015 Verified
Royalcare Super Speciality Hospitals logo

Royalcare Super Speciality Hospitals

Healthcare & Hospitals
₹155-3.13%

vs. prev. close ₹160

52W High

₹160

52W Low

₹125

Market cap

₹3,176 Cr

IPO stage

No DRHP filed

CIN

U85100TZ2012PLC018984

Price History

52W High

₹160

52W Low

₹125

About Royalcare Super Speciality Hospitals

RoyalCare Super Speciality Hospital Limited, a Coimbatore-based multi-disciplinary hospital, grew FY26 revenue 25.75% to Rs 448.90 crore and PAT 175.45% to Rs 26.11 crore (EPS Rs 1.33, ROE 5.80%), with Book Value per Share rising to Rs 21.99 amid continued capacity expansion and a proposed Rs 0.20 per share dividend.

The Short Version :

RoyalCare Super Speciality Hospital Limited, based in Coimbatore, Tamil Nadu, operates a super speciality hospital offering multi-disciplinary healthcare services. FY26 revenue from operations grew 25.75% to Rs 448.90 crore from Rs 356.99 crore, with PAT up 175.45% to Rs 26.11 crore from Rs 9.48 crore. EPS (Basic and Diluted) came in at Rs 1.33 versus Rs 0.53 a year earlier, with ROE at 5.80% (up from 3.00%) and Book Value per Share of Rs 21.99, up from Rs 15.43. The Board has recommended a final dividend of Rs 0.20 per equity share for FY26.


Why It Trades Where It Does :

RoyalCare's case is margin expansion alongside strong growth: PAT growth (175.45%) far outpaced revenue growth (25.75%), pointing to real operating leverage as the hospital's fixed cost base (facilities, doctors, equipment) is spread across a larger revenue base. Finance costs actually fell 27.28% even as the balance sheet grew substantially, Property, Plant & Equipment nearly doubled to Rs 610.80 crore, alongside continued Capital Work in Progress of Rs 300.92 crore, consistent with an active capacity expansion. Total Equity grew 42.44% to Rs 450.50 crore, aided by fresh equity share capital raised during the year (Rs 188.66 crore to Rs 204.91 crore). ROE at 5.80%, while improved, remains modest relative to the scale of capital deployed, typical of a hospital business still absorbing a large capex cycle.


Top Risks :

  • The company is proposing to issue Equity Shares with Differential Voting Rights (DVR) carrying 74% of total voting power on just a 10.50% economic stake, a governance structure that would concentrate control well beyond the promoters' equity ownership.

  • ROE of 5.80%, while improving, remains modest relative to the scale of capital deployed (Rs 450.50 crore of equity, Rs 552.50 crore of borrowings), reflecting a business still absorbing a large capex cycle.

  • As a single-hospital healthcare provider, revenue is concentrated in one facility and geography (Coimbatore), without the diversification of a multi-hospital chain.

Top Opportunities :

  • PAT growth (175.45%) far outpacing revenue growth (25.75%) shows the hospital scaling profitably as recent capacity investments mature.

  • Continued heavy capex (Capital Work in Progress of Rs 300.92 crore) signals further capacity expansion ahead, a potential driver of future revenue growth.

  • A maintained dividend payout alongside strong profit growth signals management's confidence in sustaining returns to shareholders through the expansion phase.


Disclaimer :

Priveq.in is an informational platform for unlisted and pre-IPO shares, operated by Priveq Investech Private Limited (the named counterparty on transactions). Unlisted shares carry risks including illiquidity, valuation uncertainty, and limited regulatory disclosure. This page is informational only and does not constitute investment advice.

Company Details

Industry

Healthcare & Hospitals

Founded

2015

Headquarters

Coimbatore, Tamil Nadu, India

Min Lot Size

100

Face Value

₹10.00

Total Shares

204908478

Regulatory Information

Corporate Identity Number (CIN)

U85100TZ2012PLC018984

PAN Number

AAGCR1968R

ISIN

INE02C801010

Key Valuation Ratios

As of FY2026 Annual · updated 25 Sept 2026Derived

Valuation

Market Cap

₹3,176.08 Cr

P/E Ratio

121.64×

P/S Ratio

7.08×

P/B Ratio

7.05×

EV / EBITDA

44.69×

Returns & Per Share

ROE

5.80%

EPS

₹1.27

Book Value / Share

₹21.99

Solvency

Debt / Equity

1.23×

Interest Coverage

3.08×

Company Fundamentals

As of FY2026 Annual · updated 25 Sept 2026

Gross Profit

₹351.20 Cr

EBITDA

₹83.12 Cr

Revenue Growth

25.75%

Profit Margin

5.82%

Performance Trends

5 annual periods · derived from filed statements

As of FY2026 Annual · updated 25 Sept 2026

Revenue

₹ Cr

Net Profit

₹ Cr · losses in red

Earnings Per Share

₹ per share

Return on Equity

ROE %

Return on Capital Employed

ROCE %

Debt-to-Equity

1.23×

EBITDA Margin

18.52%

Interest Coverage

3.08×

Financial Statements

As of FY2026 Annual · updated 25 Sept 2026
Disclosed reportedDerived calculated
Line itemFY2022FY2023FY2024FY2025FY2026
Total Income
Revenue from operationsDisclosed301.15₹ Crore305.49₹ Crore332.73₹ Crore356.99₹ Crore448.9₹ Crore
Other incomeDisclosed4.22₹ Crore5.16₹ Crore5.19₹ Crore4.33₹ Crore5.92₹ Crore
Total IncomeDerived305.37₹ Crore310.65₹ Crore337.92₹ Crore361.32₹ Crore454.82₹ Crore
Expenses
Cost of goods soldDisclosed71.23₹ Crore68.57₹ Crore72.76₹ Crore73.45₹ Crore97.7₹ Crore
Purchases of stock-in-tradeDisclosed26.16₹ Crore29.81₹ Crore33.66₹ Crore34.31₹ Crore41.7₹ Crore
Changes in inventoriesDisclosed-32₹ Lakh-27₹ Lakh-1.95₹ Crore1.18₹ Crore0₹ Crore
Employee benefits expenseDisclosed52.54₹ Crore53.8₹ Crore54.09₹ Crore64.86₹ Crore79.85₹ Crore
Finance costsDisclosed27.17₹ Crore26.84₹ Crore22.15₹ Crore22.24₹ Crore16.17₹ Crore
Depreciation and amortization expenseDisclosed23.72₹ Crore24.39₹ Crore24.53₹ Crore34.36₹ Crore33.34₹ Crore
Manufacturing expensesDisclosed0₹ Crore0₹ Crore0₹ Crore0₹ Crore0₹ Crore
Operating expensesDisclosed0₹ Crore0₹ Crore0₹ Crore0₹ Crore0₹ Crore
Other expensesDisclosed83.55₹ Crore91.95₹ Crore108.36₹ Crore117.44₹ Crore152.45₹ Crore
Total ExpensesDerived284.05₹ Crore295.09₹ Crore313.6₹ Crore347.84₹ Crore421.21₹ Crore
Profit
Exceptional itemsDisclosed0₹ Crore0₹ Crore0₹ Crore0₹ Crore0₹ Crore
Profit before taxDerived21.32₹ Crore15.56₹ Crore24.32₹ Crore13.48₹ Crore33.61₹ Crore
Current tax expenseDisclosed9₹ Lakh-12₹ Lakh-16₹ Lakh4₹ Crore7.5₹ Crore
Deferred tax expenseDisclosed0₹ Crore0₹ Crore0₹ Crore0₹ Crore0₹ Crore
Tax expenseDisclosed9₹ Lakh-12₹ Lakh-16₹ Lakh4₹ Crore7.5₹ Crore
Profit After TaxDerived21.23₹ Crore15.68₹ Crore24.48₹ Crore9.48₹ Crore26.11₹ Crore
Other comprehensive incomeDisclosed0₹ Crore0₹ Crore0₹ Crore24₹ Lakh54₹ Lakh
Total Comprehensive IncomeDerived21.23₹ Crore15.68₹ Crore24.48₹ Crore9.72₹ Crore26.65₹ Crore

Documents Library

Access all financial reports and filings

Annual Report

annual report 2026

2026
4.3 MB

annual report 2024

2024
18.2 MB

annual report 2022

2022
45.7 MB

annual report 2023

2023
13.3 MB

annual report 2025

2025
13.1 MB

Document

EGM of Royalcare Hospital for Private Placement ot

1.1 MB

Shareholding Pattern

Others

86.30%

Promoters

13.70%

D

Dr. K. Madeswaran

Chairman & MD

25+

D

Dr. K. Chockalingam

Director

25+

S

Sri. T.Balachander

Director & CFO

25+

EGM of Royalcare Hospital for Private Placement others Company is seeking shareholder approval to issue up to 6 crore equity shares via private placement to raise funds.

others
13/09/2025

EGM of Royalcare Hospital for Private Placement others Company is seeking shareholder approval to issue up to 6 crore equity shares via private placement to raise funds.

Express buy interest

No commitment — the desk will reach out

Current Price

₹155
-3.13%
Min lot: 100
Price/share₹155
Quantity100
Estimated Total₹15,500

Secure & Verified Transaction

Unlisted shares are illiquid and carry higher market risks. Please read the Risk Disclosure before investing.

Talk to a Specialist

Get expert guidance on this investment

52 Week Range
₹125
₹160

About Royalcare Super Speciality Hospitals unlisted shares

Indicative · updated daily

Royalcare Super Speciality Hospitals unlisted share price today

Royalcare Super Speciality Hospitals unlisted share price today is ₹155 as of 16 October 2026.

Royalcare Super Speciality Hospitals — frequently asked questions

What is the grey market price for Royalcare Super Speciality Hospitals?

No IPO is currently announced for Royalcare Super Speciality Hospitals, so no grey market exists; the price above reflects Priveq's own desk valuation.

Has Royalcare Super Speciality Hospitals filed for an IPO, and when might it list?

Royalcare Super Speciality Hospitals has not filed a draft red herring prospectus, so no IPO is currently announced and no listing date has been set.

How does Royalcare Super Speciality Hospitals compare to its listed peers?

There is no closely comparable listed company for Royalcare Super Speciality Hospitals in India today.

Is Royalcare Super Speciality Hospitals on the SME or Mainboard IPO track?

Royalcare Super Speciality Hospitals has not filed a draft red herring prospectus, so no IPO track is set yet.

What is Royalcare Super Speciality Hospitals's CIN and registered office?

Royalcare Super Speciality Hospitals's Corporate Identity Number is U85100TZ2012PLC018984, registered at Coimbatore, Tamil Nadu, India.

What is Royalcare Super Speciality Hospitals's market capitalisation?

Royalcare Super Speciality Hospitals's market capitalisation is approximately ₹3,176 crore, based on its current unlisted share price.

All Healthcare & Hospitals →

Buying, selling and holding unlisted shares

Applies to every company on Priveq
How do I buy Royalcare Super Speciality Hospitals unlisted shares?

Priveq Investech Private Limited is the named counterparty on every transaction. To buy Royalcare Super Speciality Hospitals unlisted shares: complete KYC once (PAN, Aadhaar, bank details, and demat account information — SEBI-compliant, typically approved within 24 hours), then submit your order through your Priveq dashboard specifying quantity. Our team confirms price and payment details with you directly. Once payment is confirmed, Royalcare Super Speciality Hospitals shares are transferred off-market straight to your demat account, with no pooling and no middlemen.

How do I sell Royalcare Super Speciality Hospitals unlisted shares?

Submit an Express Sell Interest for Royalcare Super Speciality Hospitals through your Priveq dashboard, specifying quantity, the same way a buy order is placed. Priveq quotes you a bid price, which may differ from the live Buy price shown to buyers, since unlisted-share pricing works on a bid-ask basis rather than a single quote. Once you accept, you'll need to provide your Client Master List (CML), a cancelled cheque or bank details, and PAN. If you hold shares with CDSL, transfer can also be completed digitally via CDSL Easiest. You transfer Royalcare Super Speciality Hospitals shares to Priveq first, and payment follows once the transfer is confirmed received, typically the same day, T+1, or occasionally T+2, communicated to you directly. For sizeable transactions worth crores of rupees, an escrow arrangement can be used instead, at the sole consent of both parties.

What is the minimum investment for Royalcare Super Speciality Hospitals unlisted shares?

Minimum investment varies by company and is shown as the Min Investment figure on this page. Royalcare Super Speciality Hospitals's minimum is ₹15,500.

Is there a maximum investment limit?

There's no fixed maximum investment limit for Royalcare Super Speciality Hospitals unlisted shares. For sizeable transactions worth crores of rupees, an escrow arrangement can be used at the sole consent of both parties, the same mechanism available on the sell side.

Is buying Royalcare Super Speciality Hospitals unlisted shares legal in India?

Yes. Buying and selling unlisted shares in India is legal and is subject to relevant SEBI regulations, including the mandatory lock-in period after listing, stamp duty, and depository participant charges on each transaction. Priveq's own KYC process is built to be SEBI-compliant.

What is the lock-in period for Royalcare Super Speciality Hospitals unlisted shares?

Royalcare Super Speciality Hospitals has not filed a DRHP yet, so no listing date or lock-in period applies at this stage. Once an IPO is filed, this answer updates to reflect the applicable SME or Mainboard lock-in.

What happens if Royalcare Super Speciality Hospitals's IPO is delayed or withdrawn?

If an IPO is delayed, shares remain unlisted and continue to trade on the desk at Priveq's indicative price, with no lock-in in effect until an actual listing happens. If a company formally withdraws its DRHP, the same applies: shares stay unlisted, with no lock-in period until and unless a fresh IPO process begins.

How are capital gains on Royalcare Super Speciality Hospitals unlisted shares taxed?

If you sell unlisted shares, including Royalcare Super Speciality Hospitals, within 24 months of purchase, the gain is taxed as short-term capital gain at your applicable income tax slab rate. Beyond 24 months, it is taxed as long-term capital gain at 12.5 percent, without indexation benefit, under the rules effective from 23 July 2024. If Royalcare Super Speciality Hospitals lists and you sell after listing, the applicable tax treatment shifts to listed-security rates, with the holding period still measured from your original unlisted purchase date. This is general information, not tax advice; investors should confirm their specific position with a tax advisor.

Can NRIs invest in Royalcare Super Speciality Hospitals unlisted shares?

Yes, on a non-repatriable basis. NRIs can invest using funds from an NRO account; sale proceeds stay within India unless repatriated separately under RBI's own limits. Priveq does not currently support repatriable investment (NRE/FCNR-funded), which would require the investee company to file additional RBI paperwork as foreign direct investment.

Does Priveq charge a platform fee on top of the share price?

No. The price quoted to you is all-in; there is no separate platform fee or brokerage added on top.

How does Priveq determine the desk price for Royalcare Super Speciality Hospitals?

Priveq's desk price reflects several inputs together, not a single formula: the seller's ask price at the time, current demand and supply on the platform for Royalcare Super Speciality Hospitals specifically, broader sentiment in the unlisted and pre-IPO market, how Royalcare Super Speciality Hospitals's sector and listed peers are trading, the company's own recent financial performance and IPO-stage developments, and recent transaction history where deals have actually closed.

Because unlisted shares trade over the counter rather than on an exchange, this price is indicative, not a continuously live quoted market price, and the actual deal price is confirmed with you directly before a transaction closes.

Is Priveq SEBI-registered? Does it give investment advice?

Priveq is not a SEBI-registered stock exchange and not a SEBI-registered investment adviser. Priveq Investech Private Limited operates Priveq.in as a research and information platform for unlisted and pre-IPO shares, and is the named counterparty on transactions executed through the platform. Nothing on this page is investment advice; it's information to help you evaluate a company and decide for yourself.

Am I eligible to invest through Priveq if I'm not an HNI?

Yes. Priveq isn't a stock exchange with membership restrictions, and investing isn't limited to HNIs. Depending on the company, entry points can start as low as ₹20,000, though the minimum for any specific company is shown as the Min Investment figure on its page.

What documents do I receive after buying unlisted shares?

You receive an email acknowledging and confirming your order, along with a deal note or invoice recording the transaction details.

What happens to my shares or money if a deal falls through?

Because Priveq is the direct counterparty on every transaction rather than just connecting a buyer and seller, this risk sits with Priveq, not with you. If a deal falls through after you've committed funds or shares, they remain safe, and Priveq guarantees a refund.

Chat with us